col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


36 Results       Page 1

 [1] 
Elsevier: Biochemistry and Biophysics Reports
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―05 Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes Reo Kanechi, Tatsuya Shishido, Mana Tachikawa, Tomohiro Nishimura, Akihito Sawada, Hayato Okade, et al. (+3)
2 [GO] 2025―Mar―13 In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs Shamiya Anwar Kizhakkiniyakath, Tejaswini Choudhury, Madhan Vishal Rajan, Sagar Rathee, Basant Meena, Gururao Hariprasad
3 [GO] 2024―Dec―17 Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic Marina dos Santos Barreto, Ronaldy Santana Santos, Eloia Emanuelly Dias Silva, Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Pamela Chaves de Jesus, et al. (+4)
4 [GO] 2024―Aug―05 Insilico assessment of hesperidin on SARS-CoV-2 main protease and RNA polymerase: Molecular docking and dynamics simulation approach Elaheh Molaakbari, Mohammad Reza Aallae, Fereshteh Golestanifar, Zahra Garakani-Nejad, Ahmad Khosravi, Mohsen Rezapour, et al. (+3)
5 [GO] 2024―Jun―13 Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches Cena Aram, Parsa Alijanizadeh, Kiarash Saleki, Leila Karami
6 [GO] 2024―Apr―29 Micro-second time-resolved X-ray single-molecule internal motions of SARS-CoV-2 spike variants Daisuke Sasaki, Tatsuya Arai, Yue Yang, Masahiro Kuramochi, Wakako Furuyama, Asuka Nanbo, et al. (+4)
7 [GO] 2023―Dec―26 Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease Zhichao Hao, Yuan Liu, Wei Guan, Juan Pan, MengMeng Li, Jiatong Wu, et al. (+3)
8 [GO] 2023―Nov―02 Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1 Olfat Shaker, Monica El Amir, Yasmine Abd Elfatah, Heba M. Elwi
9 [GO] 2023―Jun―02 Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective Sabyasachi Bandyopadhyay, Madhan Vishal Rajan, Punit Kaur, Gururao Hariprasad
10 [GO] 2023―Apr―25 Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid protein Sarah Guttmann, Sebastian Bunte, Simon Eschrig, Nils Janzen, Julia Klemens, Yara Koenemann, et al. (+5)
11 [GO] 2023―Mar―07 Blood levels of d-amino acids reflect the clinical course of COVID-19 Shihoko Kimura-Ohba, Yoshitsugu Takabatake, Atsushi Takahashi, Yoko Tanaka, Shinsuke Sakai, Yoshitaka Isaka, Tomonori Kimura
12 [GO] 2022―Nov―23 In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43 Paul Lang, Svend S. Geertsen, Alex L. Lublin, Michelle C. Potter, Tatiana Gladysheva, Jill S. Gregory, Pascal Rufi
13 [GO] 2022―Nov―07 Comparison of the inactivation capacity of various UV wavelengths on SARS-CoV-2 Ryosuke Matsuura, Chieh-Wen Lo, Takayo Ogawa, Masaru Nakagawa, Masami Takei, Yasunobu Matsumoto, et al. (+2)
14 [GO] 2022―Sep―22 In silico prediction of COVID-19 cytokine storm in lung cancer types Surabhi Suchanti, Sonali Awasthi, Gyanendra Singh, Pramod K. Yadav, Abhijeet Singh, Rajeev Mishra
15 [GO] 2022―Sep―13 Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? Anna Surgean Veterini, Cita Rosita Sigit Prakoeswa, Damayanti Tinduh, Satuman Satuman
16 [GO] 2022―Jul―01 High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2 Takuro Koshikawa, Hiroshi Miyoshi
17 [GO] 2022―Apr―21 Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19) Hamid Behrouj, Omid Vakili, Adel Sadeghdoust, Neda Aligolighasemabadi, Parnian Khalili, Mozhdeh Zamani, Pooneh Mokarram
18 [GO] 2022―Feb―01 Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data Md. Roman Mogal, Sagarika Adhikary Sompa, Asadullah Junayed, Md. Rashel Mahmod, Md. Zainul Abedin, Md. Asaduzzaman Sikder
19 [GO] 2022―Jan―31 Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, Amna M. Ali, Alaa A. Makki, Walaa Ibraheem, Abdulrahim A. Alzain
20 [GO] 2021―Dec―15 Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia David Bovard, Marco van der Toorn, Walter K. Schlage, Samuel Constant, Kasper Renggli, Manuel C. Peitsch, Julia Hoeng
21 [GO] 2021―Nov―10 Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein Gulam Rabbani, Saeyoung Nate Ahn, Hyunhwa Kwon, Khurshid Ahmad, Inho Choi
22 [GO] 2021―Jul―19 Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma Brandon Bergsneider, Elise Bailey, Yusuf Ahmed, Namrata Gogineni, Derek Huntley, Ximena Montano
23 [GO] 2021―Jul―06 Peptide inhibitors against SARS-CoV-2 2′-O-methyltransferase involved in RNA capping: A computational approach Mainak Dutta, Eldhose Iype
24 [GO] 2021―Jun―14 Shorter leukocyte telomere length is associated with severity of COVID-19 infection. Gabriel Arantes dos Santos, Ruan Pimenta, Nayara I. Viana, Vanessa R. Guimarães, Poliana Romão, Patrícia Candido, et al. (+8)
25 [GO] 2021―Jun―03 In Silico Molecular Docking Analysis for Repurposing Approved Antiviral Drugs against SARS-CoV-2 Main Protease Ibrahim Khater, Aaya Nassar
26 [GO] 2021―May―25 Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface Marcelina Ogedjo, Isaac Onoka, Mtabazi Sahini, Daniel M. Shadrack
27 [GO] 2021―May―14 Sequence and structural analysis of COVID-19 E and M protein with MERS virus E and M protein-A comparative study Ebtisam A. Aldaais, Subha Yegnaswamy, Fatimah Albahrani, Fatima Alsowaiket, Sarah Alramadan
28 [GO] 2021―Mar―29 Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor Tamim Ahsan, Abu Ashfaqur Sajib
29 [GO] 2021―Feb―27 In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis Azza H. Harisna, Rizky Nurdiansyah, Putri H. Syaifie, Dwi W. Nugroho, Kurniawan E. Saputro, Chandra D. Prakoso, et al. (+4)
30 [GO] 2021―Feb―06 SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection Iman Hassan Ibrahim, Doha El-Sayed El-lakwa
31 [GO] 2021―Jan―27 Variations in Orf3a protein of SARS-CoV-2 alter its structure and function Gajendra Kumar Azad, Parimal Kumar Khan
32 [GO] 2020―Dec―29 Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan Walid Al-Zyoud, Hazem Haddad
33 [GO] 2020―Dec―12 Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing Resal Raj
34 [GO] 2020―Nov―05 SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra
35 [GO] 2020―Oct―10 Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2 Gajendra Kumar Azad
36 [GO] 2020―Aug―20 ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity Fedaa Ali, Menattallah Elserafy, Mohamed H. Alkordi, Muhamed Amin
 [1] 

36 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec